Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.92 USD | -2.49% | -6.38% | -39.78% |
25/04 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
25/04 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.78% | 797M | |
+9.81% | 106B | |
-2.61% | 104B | |
+6.32% | 23.25B | |
-12.44% | 22.5B | |
-6.73% | 18.7B | |
-37.08% | 17.95B | |
-9.60% | 16.99B | |
+7.54% | 14.26B | |
+38.97% | 12.76B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Rating